• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Oxymorphone
Date Designated:  03/19/1985
Orphan Designation:  For relief of severe intractable pain in narcotic-tolerant patients.
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
DuPont Merck Pharmaceutical Company
P.O. Box 80027
Wilmington, Delaware 19880
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.